BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• Human BRG1 is a component of the SWI-SNF chromatin remodeling complex.
• BRG1 interacts with the tumor suppressor pRb, potentially regulating proliferation.
• The role of BRG1 in tumor suppression is under investigation.

Purpose of the Study:

• To screen tumor cell lines for mutations in the BRG1 gene.
• To investigate if BRG1 functions as a tumor suppressor gene.

Main Methods:

• Screening of human tumor cell lines for BRG1 mutations.
• Analysis of gene deletions, frameshift lesions, nonsense lesions, and point mutations.
• Reintroduction of BRG1 into cells lacking expression to assess phenotypic changes.

Main Results:

• Homozygous deletion of BRG1's COOH-terminal region in prostate and lung carcinoma cell lines.
• Biallelic inactivation of BRG1 in breast, lung, pancreas, and prostate carcinoma cell lines.
• Reintroduction of BRG1 reversed the transformed phenotype, inducing growth arrest and flattened morphology.

Conclusions:

• BRG1 mutations are present in various human tumors, suggesting it is targeted for disruption.
• BRG1 functions as a tumor suppressor, and its regulation of gene expression via chromatin remodeling is critical for cancer progression.
• Further confirmation in primary tumors is warranted.